Working with a variety of stakeholders to positively change clinical trials, making them more streamlined, efficient, and patient-focused requires transformational shifts in the design and conduct of clinical research (clinical trials). Let’s take a look at the evolution of clinical…
– Public Health Emergency The Central Drugs Standard Control Organization (CDSCO) acknowledges the potential impact of COVID-19 pandemic on the healthcare system and broader society, and the impact it may have on clinical trials and subjects. The present situation across…
FDA officials shared their insights on how drug makers can be more efficient when developing treatments for rare diseases, according to comments at the National Organization for Rare Disorders (NORD) Summit in Washington, DC. Despite the growing number of new…
In a Publication Report from the Institute of Medicine (IOM) was based on a workshop held with the focus on the importance of “Public Engagement and Clinical Trials.” As we all know that many clinical trials are slow to enroll…
In an attempt to ease norms for testing and introduction of new medicines in the country, the government has taken steps to fast-track approvals for clinical trials as well as launch of drugs already approved in other countries. Pharmaceutical companies…
Subscribe to our Newsletter
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
[fluentform id="3"]
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.